𝔖 Bobbio Scriptorium

✦ LIBER ✦

45. Functional evaluation of recombinant human N-acetylgalactosamine-6-sulfate sulfatase as enzyme replacement therapy

✍ Scribed by Melita Dvorak-Ewell; Dan Wendt; Shilpa Shroff; Vish Koppaka; Terri Christianson; Michael Vellard

Book ID: 116988479
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 44 KB
Volume: 96
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2008.11.046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterization of a recombinant N-acet

Characterization of a recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in E. coli for enzyme replacement therapy of Morquio A disease

✍ Angela Mosquera; Alexander Rodríguez; Carlos Soto; Felice Leonardi; Angela Espej 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 493 KB

Enzyme replacement therapy for mucopolys

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant humanN-acetylgalactosamine 4-sulfatase

✍ Paul Harmatz; Zi-Fan Yu; Roberto Giugliani; Ida Vanessa D. Schwartz; Nathalie Gu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 239 KB

Long-term follow-up of endurance and saf

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

✍ Paul Harmatz; Roberto Giugliani; Ida Vanessa D. Schwartz; Nathalie Guffon; Elisa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 420 KB

Enzyme replacement therapy for mucopolys

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study

✍ Paul Harmatz; Roberto Giugliani; Ida Schwartz; Nathalie Guffon; Elisa Leão Teles 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Enzyme replacement therapy for mucopolys

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study

✍ Paul Harmatz; Roberto Giugliani; Ida Schwartz; Nathalie Guffon; Elisa Leão Teles 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 276 KB